Most popular articles on this site Articles on pharmacy Articles on capitation Articles on disease management

www managedcaremag.com

Vol. 17, No. 4
April 2008

Cover Story

Mental Health Parity at Last?
A coalition of health plans, employers, legislators, and consumer advocates is bringing equal coverage closer to reality than it has ever been.

Forging a Better Cancer Policy
Health plans say that 20 percent of treatment costs can be eliminated, but oncologists are a hard sell.

Get Tough With Your PBM!
It starts with the language in the PBM contract and the request-for-proposals process. An experienced negotiator is your guide.

Could a Wal-Mart PBM Succeed?
The world’s largest retailer is putting one giant-sized toe in the waters of the pharmaceutical benefit management business.

Q&A: Bruce Bagley, MD, Urges Straight Talk
This American Academy of Family Physicians official wants doctors to get serious about quality improvement.

Managed Medicaid: A Good Place to Be
As rolls grow, states turn to health insurers for assistance, and many kinds of companies are now involved.

An Options Market for Health Care?
You, your employer, or your doctor would buy options guaranteeing the price of services you might eventually need.

Departments

Editor’s Memo
Will parity really make it this time?

Legislation & Regulation
Procecutor says UCR isn’t that at all.

News and Commentary
Consumer-Directed Plans See Bump in Enrollment
Medicare Advantage Marketing Slammed
Little change in overall rate of medical and pharmacy cost increases (chart)
Headlines on Deadline

Compensation Monitor
P4P programs too diverse?

Formulary Files
Consumers: We can’t afford Rx.

Medication Management
Making the most of OTCs.

Tomorrow’s Medicine
One physician can make a difference.

Outlook
“Boomers” enter Medicare.

Ulcerative Colitis: The Value of Persistence in Therapy

This Brief reviews a potential treatment option for patients with ulcerative colitis. This chronic inflammatory disease may significantly affect a person’s health and quality of life. A once-daily oral medication, MMX mesalamine, may be beneficial to these patients by limiting pill burden and potentially increasingly the likelihood of medication compliance.

Highlights:
  • Discussion of the incidence and prevalence of ulcerative colitis, along with its socioeconomic impact
  • Overview of the available treatment modalities, with a focus on 5-aminosalicylate therapy
  • Review of two pivotal trials that examined the efficacy of MMX mesalamine for patients with mild-to-moderative ulcerative colitis
NOW AVAILABLE
The next generation in online publishing...


Readers of P&T, Managed Care, and Biotechnology Healthcare will soon be able to enjoy the free digital version of these publications. Through this technology, readers will experience the full reading experience online. To read a sample of the digital version of Managed Care, follow this link:

Sample digital edition

Register for a free digital subscription

Archive issues of Managed Care:

Call for Manuscripts

In addition to its traditional coverage of the business of medicine, MANAGED CARE publishes academic review articles and scientific studies relating to the cost and effectiveness of programs, products, and procedures in health care financing and delivery.

E-Mail Discussion Group

Archives

Full-text archive of Managed Care magazine, January 1996-present

Subscribe

Managed Care in print

Contact us:

Send editorial inquiries and questions to:

To respond to an article for possible inclusion in the "Letters to the Editor" column, write to:

Advertising inquiries, including media kit requests:

Reprint orders or queries:

Circulation matters, including change of address and cancellations:

Questions or problems concerning this website:

By postal mail:

Managed Care
Medimedia USA
780 Township Line Road
Yardley, PA 19067

By phone and fax:

1-267-685-2788
1-267-685-2966 FAX